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Abstract
A synthetic Cl3 channel-forming peptide, C-K4-M2GlyR, applied to the apical membrane of human epithelial cell
monolayers induces transepithelial Cl3 and fluid secretion. The sequence of the core peptide, M2GlyR, corresponds to the
second membrane-spanning region of the glycine receptor, a domain thought to line the pore of the ligand-gated Cl3
channel. Using a pharmacological approach, we show that the flux of Cl3 through the artificial Cl3 channel can be regulated
by modulating basolateral K efflux through Ca2-dependent K channels. Application of C-K4-M2GlyR to the apical
surface of monolayers composed of human colonic cells of the T84 cell line generated a sustained increase in short-circuit
current (ISC) and caused net fluid secretion. The current was inhibited by the application of clotrimazole, a non-specific
inhibitor of K channels, and charybdotoxin, a potent inhibitor of Ca2-dependent K channels. Direct activation of these
channels with 1-ethyl-2-benzimidazolinone (1-EBIO) greatly amplified the Cl3 secretory current induced by C-K4-M2GlyR.
The effect of the combination of C-K4-M2GlyR and 1-EBIO on ISC was significantly greater than the sum of the individual
effects of the two compounds and was independent of cAMP. Treatment with 1-EBIO also increased the magnitude of fluid
secretion induced by the peptide. The cooperative action of C-K4-M2GlyR and 1-EBIO on ISC was attenuated by Cl3
transport inhibitors, by removing Cl3 from the bathing solution and by basolateral treatment with K channel blockers.
These results indicate that apical membrane insertion of Cl3 channel-forming peptides such as C-K4-M2GlyR and direct
activation of basolateral K channels with benzimidazolones may coordinate the apical Cl3 conductance and the basolateral
K conductance, thereby providing a pharmacological approach to modulating Cl3 and fluid secretion by human epithelia
deficient in cystic fibrosis transmembrane conductance regulator Cl3 channels. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Chloride and £uid secretion is a fundamental pro-
cess for many epithelia including those lining the air-
way and intestine. In the hereditary disease cystic
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¢brosis (CF), a mutation in the gene that encodes the
cystic ¢brosis transmembrane conductance regulator
(CFTR) Cl3 channel diminishes the apical Cl3 con-
ductance of transporting cells, thereby impairing Cl3
and £uid secretion by many of the secretory epithelia
[1^5]. We have devised a novel approach to amelio-
rate the disease by restoring the Cl3 conductance
through the insertion into the membrane of trans-
porting cells a synthetic Cl3 channel-forming peptide
derived from the pore region of a non-epithelial Cl3
channel.
M2GlyR, a synthetic peptide, mimics the 23 amino
acid sequence of the second membrane-spanning re-
gion of the K-subunit of the glycine receptor found in
the post-synaptic membranes of neurons in the brain
and spinal cord. Reddy et al. reported that this pep-
tide inserts into synthetic lipid bilayers and associates
to form a four or ¢ve peptide multimer with Cl3
conductances of 25 and 49 pS; conductances similar
to the native glycine receptor [6]. We have modi¢ed
their original sequence by adding a ‘solubilizing tail’,
consisting of four lysine residues, to the carboxy-ter-
minus to form C-K4-M2GlyR. These positively
charged residues improved the peptide’s water solu-
bility and increased the bioactivity of the peptide [7].
Application of the peptide to the apical surface of
Madin^Darby canine kidney (MDCK) cell mono-
layers induced a sustained increase in short-circuit
current (ISC) and £uid secretion that was indepen-
dent of the activation of the adenosine 3P,5P-cyclic
monophosphate (cAMP) pathway [8]. The applica-
tion of the peptide is associated with the appearance
of an anion conductance with novel characteristics
that di¡erentiate it from endogenous conductances
such as CFTR, Ca2-dependent Cl3 channels, ClC-
2 channels and volume-sensitive organic osmolyte
and anion channels [9]. The e¡ects of the peptide
are speci¢c since the application of a scrambled se-
quence of the M2GlyR peptide containing the C-ter-
minal lysine residues had no e¡ect on whole cell cur-
rent [9], Cl3 secretory current or net £uid movement
[8].
The Cl3 current induced by C-K4-M2GlyR was
accompanied by net secretion of £uid. This secretory
current was inhibited by a variety of Cl3 channel
blockers, bumetanide and by removing external Cl3
[8]. Thus, the anion conductance generated by the
membrane insertion of C-K4-M2GlyR appears to
functionally mimic the e¡ect of activating endoge-
nous Cl3 conductances, such as CFTR.
In the current study, we examined the e¡ect of C-
K4-M2GlyR on the human colonic cell line, T84,
and determined if Cl3 secretion generated by the
peptide could be modulated by pharmacological
treatment of a basolateral K channel opener, 1-eth-
yl-2-benzimidazolinone (1-EBIO). We chose to inves-
tigate this process in the T84 cell line since these cells
originated from a human epithelium that is com-
monly a¡ected in CF and is a classical cell line for
the investigation of endogenous Cl3 channels in-
volved in transepithelial Cl3 secretion. The transport
properties of these cells have been extensively exam-
ined and found to have many of the mechanisms
involved in salt and £uid secretion in the airway
and intestine [3,10^14]. A clear advantage of the
T84 cells over the MDCK cell line is that, in T84
cells, the secretion of Cl3 through activated apical
Cl3 channels can be modulated by directly activating
the basolateral K conductance [12,15,16].
2. Materials and methods
2.1. Cell culture protocol
T84 cells were originally obtained from the Amer-
ican Type Culture Collection and grown in a 1:1
mixture of Dulbecco’s modi¢ed Eagle’s medium
and Ham’s F-12 (DME/F12; JRH Biosciences, Le-
nexa, KS) supplemented with 5% fetal bovine serum
(FBS; HyClone, Logan, UT), 100 IU/ml penicillin G
and 0.1 mg/ml streptomycin (P/S). Cells were main-
tained as a subcon£uent monolayer on plastic in a
humidi¢ed atmosphere containing 5% CO2/95%
room air at 37‡C until harvested by trypsinization.
2.2. Electrical measurements
T84 cells (2.5U105) were plated on individual per-
meable supports (Snapwell, 12 mm diameter; Costar,
Cambridge, MA) and incubated in DME/F12+5%
FBS. After 5^8 days of growth, the Snapwell sup-
ports containing the con£uent cell monolayers were
mounted in Ussing chambers (Navicyte Inc., Sparks,
NV), and bathed in a Ringer’s solution containing
(in mM): 147 Na, 119 Cl3, 20 HCO33 , 6 alanine,
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5 K, 5 acetate, 5 glucose, 4 lactate, 2.5 HPO34 , 1.2
Mg2, 1.2 SO234 , 1 citrate, 0.5 butyric acid and 14 raf-
¢nose equilibrated with 5% CO2/95% O2. In experi-
ments in which we removed Cl3 from the bathing
solution, Cl3 was replaced by the molar equivalent
of cyclamate. The transepithelial potential (Vte),
short-circuit current (ISC ; the current necessary to
clamp the voltage to zero) and transepithelial resis-
tance (Rte) were measured at 5 min intervals with a
dual epithelial voltage clamp apparatus (Warner In-
strument, Hamden, CT) as previously described in
detail [8,17]. T84 cell monolayers developed resistan-
ces from 0.5 to 10 k6Wcm2. The tissue was continu-
ously short-circuited except for measurement of Vte
and Rte.
2.3. Measurement of £uid transport
T84 cells were plated onto permeable cell culture
supports (Transwell-Col, 24.5 mm diameter; Costar,
Cambridge, MA) at a seeding density of 8U105 cells/
Transwell and grown in DME/F12 containing 1%
FBS for 5^7 days. The procedure for measuring £uid
transport across epithelial cell monolayers has been
previously described [17,18]. Brie£y, the £uid bathing
the apical surface of the monolayers (upper chamber
of the Transwell) was removed and 200 Wl of fresh
DME/F12 containing 1% FBS was placed on the
apical surface. The apical £uid was covered with
1.5 ml of sterile, water-saturated mineral oil to pre-
vent £uid evaporation. The Transwells were placed in
6-well culture plates containing 2.5 ml of basolateral
medium. After 12 h, the £uid and mineral oil on the
apical surface were collected and the monolayers
were rinsed with fresh mineral oil which was recol-
lected to remove any residual £uid. The £uid and oil
mixture was centrifuged to separate the two layers,
and the £uid droplet at the bottom of the test tube
was measured using calibrated microcapillary tubes
(Drummond, Broomall, PA). The rate of £uid trans-
port was calculated from the change in apical £uid
volume during the experimental period and expressed
in nl/h/cm2. In order to eliminate possible Na ab-
sorption via Na channels, amiloride (10 WM) was
added to the apical media in all £uid transport ex-
periments. C-K4-M2GlyR was added only to the ap-
ical medium and 1-EBIO was added only to the ba-
solateral medium.
2.4. Peptide synthesis
The synthesis of C-K4-M2GlyR has been previ-
ously described [7,8]. Brie£y, the peptide was synthe-
sized using solid-phase peptide synthesis employing
an automated base-labile 9-£uorenylmethyloxycar-
bonyl (Fmoc) strategy with a p-hydroxymethylphe-
noxymethyl polystyrene-lysine resin (Applied Biosys-
tems model 431A peptide synthesizer; Perkin-Elmer,
Norwalk, CT). The peptide was assembled by the
successive step-wise repetition of deprotection of
the amino acid, activation by a condensing agent,
and coupling the amino acid to the resin. Once the
entire sequence was assembled, the peptide was
cleaved from the resin, extracted and dried by ly-
ophilization. The peptide was puri¢ed by reverse-
phase HPLC and the correct sequence was con¢rmed
using a protein sequencer (Applied Biosystems; Per-
kin-Elmer). The amino acid sequence of C-K4-
M2GlyR is PARVGLGITTVLTMTTQSSGSRAK-
KKK.
2.5. cAMP measurements
Con£uent T84 cell monolayers were incubated in
de¢ned media or media containing either 500 WM
apical C-K4-M2GlyR, 600 WM basolateral 1-EBIO
or a combination of C-K4-M2GlyR and 1-EBIO
for 1 h. Monolayers were rinsed in Ca2-, Mg2-
free phosphate-bu¡ered saline. Trichloroacetic acid
(TCA) was used to deactivate the endogenous phos-
phodiesterases. TCA was removed by extraction with
a mixture of water and ether. cAMP was collected in
the water phase and concentrations were determined
by radioimmunoassay (Biomedical Technology,
Stoughton, MA).
2.6. Pharmacological agents
In electrophysiological studies, clotrimazole,
1-EBIO (Aldrich Chemical Co., Milwaukee, WI)
and amiloride were dissolved in dimethyl sulfoxide
(DMSO) as 1000-fold stock solutions. Forskolin,
A23187 and ni£umic acid were dissolved in ethanol
as 1000-fold stock solutions. The maximal ¢nal con-
centration of DMSO (0.1%) or ethanol (0.1%) was
without e¡ect on ISC. Charybdotoxin (CTX; Alo-
mone, Jerusulem, Israel) was made up as a 10 WM
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stock in bathing solution containing 0.1% bovine se-
rum albumin, to prevent non-speci¢c binding to the
glassware [19]. All medium additives and drugs were
purchased from Sigma Chemical Co. (St. Louis,
MO), unless noted otherwise.
2.7. Statistical analysis
Data are presented as means þ S.E.M. Where ap-
propriate, Student’s t-test was used to determine stat-
istical signi¢cance. Sequential measurements of the
ISC, Vte, and Rte were compared by repeated mea-
sures analysis of variance (ANOVA) and the Stu-
dent^Newman^Keuls (S-N-K) multiple comparison
post test. Measurements of £uid transport and intra-
cellular cAMP were compared by ordinary ANOVA
and the S-N-K post test. Signi¢cant e¡ects or
changes were considered to have occurred when
P6 0.05.
3. Results
3.1. E¡ect of C-K4-M2GlyR on electrical
measurements
A typical e¡ect of C-K4-M2GlyR on the electrical
properties of a T84 monolayer is illustrated in Fig. 1.
The application of 100 WM C-K4-M2GlyR to the
apical surface of the monolayer increased positive
ISC (apical to basolateral) during a 40 min exposure.
ISC began to increase 10 min after the addition of the
peptide and by 30 min ISC reached a steady level that
was 3.9 WA/cm2 above the control current. The api-
cally negative Vte hyperpolarized by 37.2 mV, fol-
lowing the same time course as the change in ISC.
The resistance across the monolayer (Rte) decreased
to 50% of the control value with the addition of
the peptide. The results of 29 such experiments are
summarized in Table 1. The addition of 100 WM
C-K4-M2GlyR to the medium bathing the apical
surface of the monolayers increased ISC ¢ve-fold,
while Vte rose by 136% and Rte decreased 54%. Prior
treatment of ¢ve T84 monolayers with 10 WM ami-
loride, a Na channel blocker, did not signi¢cantly
alter the baseline ISC and had no e¡ect on the mag-
nitude of the secretory response induced by C-K4-
M2GlyR.
Fig. 1. E¡ect of 100 WM C-K4-M2GlyR added to the apical
medium on the electrical properties of a T84 cell monolayer.
(A) ISC. (B) Vte. (C) Rte. A summary of the e¡ects of C-K4-
M2GlyR is presented in Table 1.
Table 1
E¡ect of C-K4-M2GlyR on the electrical measurements across T84 monolayers
ISC (WA/cm2) Vte (mV) Rte (k6Wcm2)
Control 1.0 þ 0.1 35.2 þ 0.7 4.56 þ 0.47
100 WM C-K4-M2GlyR 4.6 þ 0.2* 312.3 þ 1.2* 2.50 þ 0.212
Values are means þ S.E.M.; n = 29. *Comparison to the control period, P6 0.0001; 2P6 0.05. C-K4-M2GlyR (100 WM) was added to
the apical media in all experiments.
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The increase in ISC caused by C-K4-M2GlyR was
compared to the current generated by activating en-
dogenous cAMP-dependent anion secretion. In ten
monolayers, 10 WM forskolin, an adenylate cyclase
agonist, increased ISC by 4.0 þ 0.6 WA/cm2,
(P6 0.0001). Thus, the current induced by the appli-
cation of the Cl3 channel-forming peptide, C-K4-
M2GlyR, was approximately 90% of the forskolin-
stimulated current in T84 cells. In other experiments
(n = 2), ISC was monitored for ¢ve h after the appli-
cation of C-K4-M2GlyR. During the ¢rst hour, ISC
increased from 0.8 to 3.4 WA/cm2. This current grad-
ually decreased to 3.0 WA/cm2 during the second h,
then remained steady for the remaining three h at a
value that was 70% of the current measured at one h.
These data demonstrate that C-K4-M2GlyR induces
changes in ISC, Vte, and Rte that would be expected
from insertion of an anion conductance into the ap-
ical membrane.
3.2. Inhibition of C-K4-M2GlyR-induced ISC by
K+ channel blockers
Two classes of K channels have been shown to
participate in the secretory process in T84 cells. One
K conductance is activated by intracellular cAMP
and is sensitive to Ba2. The other K channel is
activated by an elevation in intracellular Ca2, is
insensitive to Ba2, and is potently inhibited by cha-
rybdotoxin (CTX) [14,16,20,21]. Clotrimazole, an
antimycotic agent, has been shown to inhibit both
populations of K channels in T84 cells, but with
di¡erent a⁄nities. The apparent inhibition constant
(Ki) for the Ca2-dependent K current was 0.3 WM,
whereas the apparent Ki for the cAMP-mediated K
conductance was 5.2 WM [12]. We ¢rst used clotri-
mazole to evaluate the K conductive pathway in-
volved in the secretory response mediated by the ap-
plication of C-K4-M2GlyR (Fig. 2). Either 100 WM
C-K4-M2GlyR was added to the apical surface
or 10 WM forskolin was added to the basolateral
surface of four pairs of T84 monolayers. When a
steady-state response was achieved (V40 min), in-
creasing concentrations of clotrimazole were added
to the basolateral media and the degree of inhibition
of the stimulated ISC was determined (Fig. 2). The
concentration of clotrimazole that inhibited 50% of
the current (IC50) induced by C-K4-M2GlyR was
approximately 0.4 WM. A higher concentration of
clotrimazole was required to inhibit the forskolin-
stimulated current (approximate IC50 = 6 WM).
In other experiments (n = 6), we tested the e¡ect of
CTX on the ISC response to C-K4-M2GlyR. In the
control monolayers, the application of 100 WM C-
K4-M2GlyR to the apical medium increased ISC by
2.0 þ 0.1 WA/cm2 (P6 0.001) (Fig. 3). In a paired
group of monolayers treated with 50 nM CTX on
the basolateral surface, the addition of the peptide
increased ISC by only 0.9 þ 0.2 WA/cm2. Thus, CTX
reduced the response of the peptide to 42% of that
generated by the control group (P6 0.001). These
data suggest that the Ca2-activated K channel par-
ticipates in the secretory response to C-K4-M2GlyR,
apparently by maintaining the electrical gradient
driving Cl3 e¥ux.
3.3. E¡ect of 1-EBIO
Recently a benzimidazolone, 1-EBIO, has been
evaluated as a novel tool for inducing Cl3 secretion
by T84 cells. Using cell monolayers, membrane
Fig. 2. E¡ect of varying concentrations of clotrimazole on ISC
in T84 cell monolayers stimulated with 10 WM basolateral for-
skolin (a) or 100 WM apical C-K4-M2GlyR (b). The increase
in ISC caused by either forskolin or the peptide was assigned to
100%. Concentration of clotrimazole added to the basolateral
medium was sequentially increased after the response to the
previous addition had reached a steady state; n = 4 pairs of
monolayers. Data represent means þ S.E.M. Dashed line, 50%
of the stimulated current. The concentration of clotrimazole re-
quired to inhibited 50% of the current generated by the peptide
was lower (apparent IC50 = 0.4 WM) than the concentration re-
quired to inhibit 50% of the current stimulated by forskolin
(apparent IC50 = 6 WM).
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vesicles, and excised inside-out patches of T84 cell
membranes, Devor and associates demonstrated
that 1-EBIO stimulates Cl3 secretion via the direct
activation of the Ca2-dependent K channels [16].
This K conductance was potently inhibited by CTX
and clotrimazole [12,16]. In the current study, the
addition of 600 WM 1-EBIO to both the apical and
basolateral media caused a rapid increase in ISC from
1.3 þ 0.2 to 5.0 þ 0.8 WA/cm2, (P6 0.05) within
5 min. The e¡ect remained constant during the
20 min period. Vte hyperpolarized from 34.2 þ 0.4
to 313.4 þ 1.7 mV, (P6 0.001) and Rte decreased
from 2.91 þ 0.17 to 2.39 þ 0.06 k6Wcm2 (P6 0.001).
To determine if the direct activation of K chan-
nels would alter the secretory response induced by
the insertion of exogenous Cl3 channels, we treated
the apical surface of six T84 cell monolayers with C-
K4-M2GlyR, then added various concentrations of
1-EBIO to the basolateral medium only (Fig. 4).
Each data point represents the increase in ISC above
the control value (vISC). The ¢rst data point (C) is
the average change in ISC obtained with apical appli-
cation of C-K4-M2GlyR. ISC recorded with subse-
quent additions of 1-EBIO (10 WM to 1 mM) are
plotted against the log scale of the 1-EBIO concen-
tration. The addition of 100 WM C-K4-M2GlyR in-
creased ISC by 4.1 þ 0.7 WA/cm2. Subsequent addi-
tions of 1-EBIO increased ISC above the e¡ect of
the peptide in a dose-dependent manner. A signi¢-
cant increase in peptide-induced ISC was recorded for
concentrations at and above 100 WM 1-EBIO.
The changes in the electrical properties of 16
monolayers exposed to 1-EBIO and C-K4-M2GlyR
are summarized in Table 2. Basolateral addition of
600 WM 1-EBIO induced a small increase in ISC and
doubled Vte ; only a nominal decrease in Rte was
observed. The apical application of 100 WM C-K4-
M2GlyR to the 1-EBIO-treated monolayers caused
an eight-fold increase in ISC from 2.1 þ 0.2 to
16.5 þ 0.9 WA/cm2 (P6 0.001), hyperpolarized Vte
by 37.3 þ 0.5 (P6 0.001) and reduced Rte by
1.53 þ 0.33 k6Wcm2 (P6 0.001). In two of these ex-
periments, the duration of the response of 1-EBIO
and C-K4-M2GlyR was monitored for 5 h. ISC re-
mained relatively constant during the ¢rst 60 min;
however, ISC had decreased to 73% of this current
at 2 h, 53% at 3 h, 41% at 4 h and 29% of the current
at 5 h. In washout experiments (n = 2), the current
generated by the additions of 1-EBIO and C-K4-
M2GlyR was monitored until the e¡ect reached a
steady state, then C-K4-M2GlyR was washed out
Table 2
Changes in electrical properties of T84 monolayers induced by 1-EBIO and C-K4-M2GlyR
ISC (WA/cm2) Vte (mV) Rte (k6Wcm2)
Control 0.8 þ 0.1 32.9 þ 0.6 2.68 þ 0.47
600 WM 1-EBIO 2.1 þ 0.22 36.2 þ 1.3* 2.27 þ 0.352
100 WM C-K4-M2GlyR+1-EBIO 16.5 þ 0.9* 313.5 þ 1.1* 0.74 þ 0.06*
Values are means þ S.E.M.; n = 16. In all experiments, 1-EBIO was added to the basolateral medium and C-K4-M2GlyR was added
to the apical medium. *Signi¢cant di¡erence compared to previous period as determined by repeated measures ANOVA and S-N-K
multiple comparison post test, P6 0.001. 2Not signi¢cant by ANOVA; however, in a paired Student t-test compared with the control
value, P6 0.0001.
Fig. 3. E¡ect of basolateral application of charybdotoxin on
ISC induced by C-K4-M2GlyR and 1-EBIO. n = 6 pairs of
monolayers. (A) The e¡ect of apical application of 100 WM C-
K4-M2GlyR on ISC in the control monolayers. (B) The e¡ect
of basolateral addition of 50 nM CTX and the subsequent ap-
plication of C-K4-M2GlyR. *P6 0.001 compared with the pre-
vious period; 2P6 0.001 compared with the C-K4-M2GlyR pe-
riod in the control group.
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of the chamber. The removal of C-K4-M2GlyR from
the medium decreased ISC by 39%, whereas the sub-
sequent removal of 1-EBIO decreased the current to
control level.
3.4. Intracellular cAMP measurements
We determined whether the response of C-K4-
M2GlyR and 1-EBIO on ISC was mediated through
the activation of endogenous mechanisms dependent
on the generation of cAMP. Intracellular cAMP was
measured by radioimmunoassay in groups of ¢ve
T84 monolayers treated with either control media,
500 WM apical C-K4-M2GlyR, 600 WM 1-EBIO
and C-K4-M2GlyR, or 10 WM forskolin for 1 h.
Intracellular cAMP levels in the T84 monolayers
treated with either C-K4-M2GlyR or the combina-
tion of 1-EBIO and C-K4-M2GlyR (10.6 þ 0.8 and
13.8 þ 1.1 pg/monolayer, respectively) were not sig-
ni¢cantly di¡erent from the level measured in the
control monolayers (6.5 þ 0.6 pg/monolayer). The ad-
dition of 10 WM forskolin increased the level of
cAMP to 80.5 þ 7.2 pg/monolayer (P6 0.001). These
data indicate that forskolin stimulates Cl3 secretion
by T84 cells through the activation of a cAMP path-
way, consistent with previous reports [10^13,15].
However, the current induced by the application of
the peptide and 1-EBIO was independent of the
cAMP-dependent pathway.
3.5. E¡ect of changes in cell calcium levels
To determine if an elevation in cell calcium is in-
volved in the response of T84 cells to C-K4-M2GlyR
and 1-EBIO, we examined the e¡ect of increasing
intracellular Ca2 levels with the Ca2 ionophore
A23187 on steady-state current and the current gen-
erated by the peptide and 1-EBIO. The average base-
line current for the four monolayers was 2.9 þ 0.1
WA/cm2. Two of the monolayers (control group)
were sequentially treated with C-K4-M2GlyR (100
WM) and 1-EBIO (600 WM) while the other two
monolayers were treated with the Ca2 ionophore
A23187 (1 WM) for 20 min prior to the addition of
the peptide and 1-EBIO. Treatment with A23187 did
not alter steady-state ISC (average increase was
0.1 WA/cm2) or the response to C-K4-M2GlyR (ISC
increased to an average of 4.2 versus 4.3 WA/cm2 in
the control group). However, the response to a sub-
sequent addition of 1-EBIO was augmented by 76%
by the prior treatment with A23187 (ISC increased to
an average of 28.7 versus 16.3 WA/cm2 in the control
group). Thus a rise in cell Ca2 concentration failed
to produce a sustained increase in ISC by itself, in-
dicating that the current generated by the peptide
and C-K4-M2GlyR is not due to elevations in cell
Ca2. A23187 treatment also failed to potentiate the
secretory response to C-K4-M2GlyR but did increase
the response to 1-EBIO.
3.6. E¡ect of K+ channel blockers on ISC induced by
C-K4-M2GlyR and 1-EBIO
We next determined whether the potentiating e¡ect
of 1-EBIO on the current induced by C-K4-M2GlyR
was dependent on basolateral K channels. In six
pairs of T84 monolayers, we evaluated the e¡ect of
Fig. 4. E¡ect of varying concentrations of 1-EBIO on ISC in-
duced by C-K4-M2GlyR. Subsequent to the increase in ISC
generated by the addition of 100 WM C-K4-M2GlyR (C), in-
creasing concentrations of 1-EBIO were added to the basolater-
al medium in a step-wise fashion following a stable response to
the previous addition. Data represents mean þ S.E.M. n = 6
monolayers. *Signi¢cant di¡erence compared to the addition of
C-K4-M2GlyR alone (C), determined by repeated measures
ANOVA and S-N-K multiple comparison post test, P6 0.05.
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basolateral application of clotrimazole on the current
induced by the combination of C-K4-M2GlyR and
1-EBIO. One group of monolayers received C-K4-
M2GlyR followed by the addition of basolateral
1-EBIO (Fig. 5A). The combined e¡ect of the pep-
tide and 1-EBIO increased ISC 11.5 þ 1.0 WA/cm2
above the control level (P6 0.001). The other group
(Fig. 5B) received 1-EBIO prior to the addition of
the peptide. The current increased by 12.4 WA/cm2
with the combination of the two additions. In each
set of experiments, the current induced by C-K4-
M2GlyR and 1-EBIO was inhibited 89 þ 1% by the
basolateral application of 5 WM clotrimazole.
In other experiments (n = 4), we tested the e¡ect of
CTX, a more speci¢c inhibitor of the Ca2-depen-
dent K channels, on the current generated by the
combination of C-K4-M2GlyR and 1-EBIO. In this
study, the additions of 100 WM C-K4-M2GlyR and
600 WM 1-EBIO increased ISC from 1.4 þ 0.2 to
6.8 þ 1.3 WA/cm2 (P6 0.01). CTX (50 nM) applied
to the basolateral surface of the monolayer reduced
this current to 2.6 þ 0.2 WA/cm2 (P6 0.01). These
studies indicate that 1-EBIO potentiates the secretory
response induced by C-K4-M2GlyR and that this
e¡ect is dependent on the activity of Ca2-dependent
K channels.
3.7. E¡ect of Cl3 transport inhibitors
We next examined the e¡ects of the Cl3 transport
inhibitors, bumetanide and ni£umic acid (NFA) on
the ISC induced by the combination of 1-EBIO and
C-K4-M2GlyR (Table 3). In four monolayers, block-
ing Cl3 entry with the basolateral addition of bume-
tanide (20 WM), an inhibitor of the Na-K-2Cl3
cotransporter, decreased the current by 71 þ 2%
Fig. 6. E¡ect of C-K4-M2GlyrR in the presence and absence of
extracellular Cl3. Bars represent means þ S.E.M. n = 4 pairs of
monolayers. Normal Cl3 concentration was 119 mM. In zero
Cl3 medium, Cl3 was replaced with 119 mM cyclamate. C-K4-
M2GlyR (100 WM) was added to the apical medium and
1-EBIO (600 WM) was added to the basolateral medium.
*P6 0.01, comparison with previous period. 2P6 0.001, com-
parison with normal Cl3 group.
Fig. 5. E¡ect of basolateral clotrimazole on the ISC generated
by the combination of apical addition of 100 WM C-K4-
M2GlyR and basolateral addition of 600 WM 1-EBIO. (A) C-
K4-M2GlyR was added 40 min prior to the subsequent applica-
tion of 1-EBIO. (B) 1-EBIO was added to the medium for 20
min before the apical application of the peptide. Clotrimazole
(5 WM) was added to the basolateral medium.
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(P6 0.001). Bumetanide also caused a signi¢cant de-
polarization of Vte from 310.0 þ 0.2 to 33.4 þ 0.3
mV, P6 0.001). Rte increased slightly, however, the
e¡ect was not signi¢cant. Previously, we showed
that the Cl3 channel blocker, NFA, was an inhi-
bitor of the C-K4-M2GlyR-generated ISC in
MDCK monolayers [8]. In four experiments, the
addition of 200 WM NFA to the apical medium re-
duced the current generated by C-K4-M2GlyR and
1-EBIO by 49 þ 6% (P6 0.001) and depolarized Vte
by 4.5 þ 0.5 mV (P6 0.005). In these experiments,
the increase in Rte did not reach statistical signi¢-
cance.
3.8. Extracellular Cl3 removal
Fig. 6 summarizes the e¡ect of removing external
Cl3 on the ISC response to C-K4-M2GlyR and
1-EBIO. Four pairs of T84 monolayers, grown under
identical culture conditions, were mounted in Ussing
chambers. The control monolayers were bathed in a
normal Cl3 Ringer’s (119 mM Cl3). The other group
was bathed symmetrically in a zero Cl3 Ringer’s so-
lution, containing the molar equivalent of cyclamate.
In the control monolayers, ISC increased from
0.8 þ 0.3 to 4.6 þ 0.4 WA/cm2 (P6 0.05) with apical
addition of the peptide. The subsequent basolateral
addition of 1-EBIO increased the current to
17.8 þ 1.8 WA/cm2 (P6 0.001). In the absence of
Cl3, the e¡ect of C-K4-M2GlyR was abolished
(30.2 þ 0.1 to 0.3 þ 0.1 WA/cm2, not signi¢cant).
The successive addition of 1-EBIO produced a sig-
ni¢cant increase in ISC ; however, the magnitude of
the response was greatly reduced (1.8 þ 0.3 WA/cm2)
and was blocked by the basolateral addition of 5 WM
Fig. 7. E¡ect of C-K4-M2GlyR and 1-EBIO on £uid transport
across T84 monolayers. n = 10 monolayers were exposed to con-
trol medium, 500 WM apical C-K4-M2GlyR, 300 WM basolater-
al 1-EBIO, or a combination of C-K4-M2GlyR and 1-EBIO.
*P6 0.001 compared with the control group of monolayers;
2not signi¢cantly di¡erent from control. 3P6 0.05 compared
with the C-K4-M2GlyR and the 1-EBIO groups of monolayers.
In another group of monolayers (n = 6), 10 WM forskolin stimu-
lated £uid secretion at a rate of 338 þ 40 nl/h/cm2 compared to
10 þ 22 nl/h/cm2 in the control monolayers (P6 0.001).
Table 3
E¡ect of chloride transport inhibitors on the changes in the electrical measurements induced by 1-EBIO and C-K4-M2GlyR in T84
monolayers
ISC (WA/cm2) Vte (mV) Rte (k6Wcm2)
Bumetanide (n = 4)
Control 0.5 þ 0.1 30.9 þ 0.1 1.39 þ 0.16
1-EBIO 1.3 þ 0.1 31.9 þ 0.2* 1.36 þ 0.16
1-EBIO+C-K4-M2GlyR 16.0 þ 0.9* 310.0 þ 0.2* 0.59 þ 0.05*
1-EBIO+C-K4-M2GlyR+bumetanide 5.0 þ 0.2* 33.4 þ 0.3* 0.06 þ 0.04
Ni£umic acid (n = 4)
Control 1.0 þ 0.1 32.1 þ 0.6 1.67 þ 0.41
1-EBIO 1.9 þ 0.5 33.8 þ 1.3 1.59 þ 0.36
1-EBIO+C-K4-M2GlyR 17.9 þ 1.5* 312.9 þ 2.1* 0.64 þ 0.052
1-EBIO+C-K4-M2GlyR+NFA 9.7 þ 1.6* 38.4 þ 2.12 0.80 þ 0.10
Values are means þ S.E.M.; n = 4 for each series of experiments. In all experiments, 1-EBIO (600 WM) was added to the basolateral
medium and C-K4-M2GlyR (100 WM) was added to the apical medium. Bumetanide (20 WM) was added to the basolateral medium.
Ni£umic acid (NFA, 200 WM) was added to the apical medium. *Signi¢cant di¡erence compared to previous period as determined by
repeated measures ANOVA and S-N-K multiple comparison post test, P6 0.001. 2P6 0.05.
BBAMEM 77786 21-2-00
D.P. Wallace et al. / Biochimica et Biophysica Acta 1464 (2000) 69^82 77
clotrimazole (data not shown). These results demon-
strate that the activation of basolateral K channels
with 1-EBIO potentiates the secretion of Cl3 through
exogenous Cl3 channels generated by the membrane
insertion of C-K4-M2GlyR.
3.9. Fluid secretion by T84 monolayers
We next determined whether the addition of
1-EBIO would increase the secretion of £uid induced
by the apical application of C-K4-M2GlyR to T84
cell monolayers. For this study, T84 cells were grown
as con£uent monolayers on Transwell-Cols for mea-
surement of £uid transport. In four groups of
10 monolayers, we measured the rate of £uid trans-
port across the monolayers. Group I was incubated
for 12 h in control medium, in group II the apical
medium contained 500 WM C-K4-M2GlyR, in group
III the basolateral medium contained 300 WM
1-EBIO and in group IV both C-K4-M2GlyR and
1-EBIO were used (Fig. 7). For these experiments, a
lower concentration of 1-EBIO was selected to re-
duce possible activation of apical mechanisms during
the 12 h incubation period. Monolayers incubated in
control media secreted £uid at a rate of 130 þ 40 nl/h/
cm2 (P6 0.01). Incubating the monolayers in the
presence of C-K4-M2GlyR signi¢cantly increased
the rate of £uid secretion to 250 þ 20 nl/h/cm2
(P6 0.05). Basolateral addition of 300 WM 1-EBIO
in the absence of the peptide did not signi¢cantly
alter the rate of £uid transport (180 þ 30 nl/h/cm2,
not signi¢cantly di¡erent from the control group).
However, the combination of C-K4-M2GlyR and
1-EBIO increased the rate of £uid secretion to
330 þ 20 nl/h/cm2 (a value that is signi¢cantly di¡er-
ent from the other three groups, P6 0.05). These
results demonstrate that anion secretion induced by
the apical membrane insertion of C-K4-M2GlyR
drives the secretion of £uid and that the direct acti-
vation of basolateral K channels by 1-EBIO in-
creases the rate of that secretion.
4. Discussion
4.1. Channel-forming peptides
Current research in CF has focused on strategies
to restore the apical Cl3 conductance in the CFTR-
de¢cient epithelia [5,22,23]. One possible treatment
for CF is the incorporation of synthetic Cl3 chan-
nel-forming peptides into the apical membrane of the
epithelial cells to assist in restoring Cl3 and £uid
secretion. A variety of small amphipathic peptides
have been demonstrated to form ion channels includ-
ing a wide range of bacterial and insect toxins
[24,25]. The bee venom toxin, melittin, is a well
known channel-forming peptide. Melittin is an am-
phipathic, K-helical peptide composed of a 20 amino
acid transmembrane segment and four positively
charged residues on the C-terminus. The charged ter-
minal amino acids have been shown to be essential
for the aqueous solubility of the peptide. Synthetic
peptides derived from the original sequence of melit-
tin have been shown to form ion channels in lipid
bilayers [24].
In mammals, defensive antimicrobial peptides
called cryptdins are released into the crypts of the
small intestine. Recently, Lencer et al. reported that
two of the cryptdins that were examined increased
anion secretion when applied to the apical surface
of T84 monolayers [26].
Other channel-forming peptides have been synthe-
sized from sequences representing putative channel-
forming regions of endogenous ion channels. These
synthetic peptides are relatively short, with a second-
ary structure that just spans a lipid bilayer [6,27].
M2GlyR, a synthetic peptide that mimics the 23 ami-
no acid sequence in the second membrane-spanning
region of the glycine receptor, can be incorporated
into arti¢cial lipid membranes and will self-assemble
into Cl3 conductive channels [6]. We have modi¢ed
this peptide by adding four lysine residues to the
C-terminus (C-K4-M2GlyR), forming a peptide
that is similar to the structure of melittin. This mod-
i¢cation greatly improved the peptide’s water solubil-
ity and increased the bioactivity of the peptide [7]. In
lipid bilayer studies, the channel formed by the wild-
type peptide, M2GlyR, was found to have conduc-
tance levels similar to those reported for the native
glycine receptor [6,28]. M2GlyR may form a channel
by the association of ¢ve monomers into a pentamer,
analogous to the pore structure of GlyR [29]. The
properties of the modi¢ed peptide, C-K4-M2GlyR
are similar to those described for the parent se-
quence, M2GlyR [9].
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4.2. T84 cell model
The T84 cells represent an extensively character-
ized human intestinal cell line that possesses many
of the transporters common to secretory epithelia
and for that reason has been used regularly in CF
research. Chloride is transported into the cell above
its electrochemical gradient by an electrically neutral
Na-K-2Cl3 cotransporter located in the basolat-
eral membrane. Chloride channels provide an e¥ux
pathway for Cl3 across the apical membrane and
Cl3 e¥ux is driven by the transmembrane electro-
chemical gradient. Basolateral K conductance is es-
sential for maintaining a su⁄cient electrical gradient
to drive Cl3 e¥ux across the apical membrane
[16,19,21]. Activation of apical Cl3 channels without
a comparable increase in the activity of K channels
would shift the cell membrane potential towards the
Cl3 equilibrium potential and limit the electrochem-
ical driving force for Cl3 e¥ux [21,30].
4.3. C-K4-M2GlyR induces Cl3 and £uid secretion by
T84 cells
In the current study, we determined if the Cl3
channel-forming peptide, C-K4-M2GlyR, could in-
sert into the apical membrane of a human intestinal
cell line and induce Cl3 and £uid secretion. Addition
of 100 WM C-K4-M2GlyR to the medium bathing
the mucosal surface of T84 cell monolayers produced
a sustained increase in ISC (Figs. 1, 3^6 and Table 1).
This response began approximately 10 min after the
application of the peptide and may represent the time
required for the insertion of the peptide and the self-
assembly of the monomers in the membrane into a
Cl3 conductive pore (Fig. 1). C-K4-M2GlyR also
caused Vte to hyperpolarize and reduced Rte, re-
sponses thought to be due to an increase in the apical
membrane Cl3 conductance (Fig. 1 and Table 1).
Basolateral application of bumetanide, an inhibi-
tor of Na-K-2Cl3 cotransport, and the apical ap-
plication of the Cl3 channel blocker NFA signi¢-
cantly attenuated ISC generated by the combination
of C-K4-M2GlyR and 1-EBIO (Table 3). In experi-
ments in which external Cl3 was replaced with cy-
clamate, the e¡ect of the peptide was completely
abolished; however, the subsequent addition of
1-EBIO produced a small increase in ISC. This cur-
rent may be attributed to HCO33 secretion through
either the channel formed by C-K4-M2GlyR or
through CFTR Cl3 channels [31].
We also found that the application of 20 nmol
(500 WM) C-K4-M2GlyR to the apical surface of
T84 monolayers nearly doubled the rate of £uid se-
cretion compared to monolayers bathed in control
media (Fig. 7), consistent with the e¡ect on
MDCK cell monolayers [8]. 1-EBIO increased £uid
secretion and the e¡ects of the combination of C-K4-
M2GlyR and 1-EBIO on £uid secretion were addi-
tive. The incremental increase in £uid secretion did
not match the magnitude of the change in ISC and
may re£ect a limiting in£uence of the water perme-
ability of the monolayers on the rate of £uid secre-
tion. These data support the hypothesis that the syn-
thetic peptide, C-K4-M2GlyR, is capable of
producing a Cl3 secretory pathway that promotes
the net secretion of solute and £uid in human intes-
tinal epithelial cells.
4.4. C-K4-M2GlyR generates a novel chloride
conductance
Evidence obtained in studies with planar lipid bi-
layers, individual MDCK and T84 cells and polar-
ized cell monolayers have demonstrated that the in-
sertion of C-K4-M2GlyR into membranes induces a
novel channel with characteristics that do not resem-
ble any known endogenous Cl3 conductance found
in either MDCK or T84 cells. The characteristics and
kinetics of the whole cell conductance generated by
exposing isolated epithelial cells to C-K4-M2GlyR
indicate that the conductance formed by the peptide
is unlikely due to the activation of CFTR, Ca2-de-
pendent Cl3 channels, ClC-2 channels or the vol-
ume-sensitive organic osmolyte and anion channels
[9]. CFTR is abundantly expressed in the T84 cells
and its channel is enhanced by agents that increase
cellular cAMP and is inhibited by high concentra-
tions of the chloride channel blocker, DPC. We
have shown that the Cl3 secretory current induced
by C-K4-M2GlyR in MDCK cells is more sensitive
to DPC than that induced by forskolin. In addition,
the peptide did not a¡ect cAMP levels in either
MDCK cells [8] or in the T84 cells. It may be argued
that the current generated by C-K4-M2GlyR is the
result of activation of endogenous CFTR Cl3 chan-
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nel by the poly-lysine tail, an e¡ect observed with
protamine applied to airway epithelial cells [32].
However, a peptide in which the M2GlyR sequence
was scrambled and to which the poly-lysine tail was
attached did not alter ISC or £uid transport [8]. In
patch clamp experiments, C-K4-M2GlyR also in-
creased Cl3 conductance in an airway epithelial cell
line derived from a human patient with cystic ¢brosis
[9].
When T84 cells are allowed to form a cell mono-
layer with tight junctions, these cells appear to down
regulate the expression of the Ca2-dependent Cl3
channel [33]. Others have reported that increasing
cellular Ca2 in T84 monolayers failed to induce an
apical Cl3 conductance [3,12]. We con¢rmed this re-
sult by testing the e¡ect of the Ca2 ionophore
A23187 on ISC across T84 monolayers. A23187 did
not produce a sustained increase in ISC. We have also
shown that DIDS, an inhibitor of the Ca2-depen-
dent Cl3 channel, did not a¡ect ISC generated by
C-K4-M2GlyR in MDCK cell monolayers [8]. The
data from whole cell recordings and from short-cir-
cuit current experiments of MDCK and T84 cell
monolayers strongly suggest that the current gener-
ated by C-K4-M2GlyR is not the result of activating
either CFTR or a Ca2-dependent Cl3 conductance.
To further examine the possibility that C-K4-
M2GlyR may be activating endogenous Cl3 chan-
nels, we applied the peptide to the basolateral aspect
of the cell. We found that basolateral application of
C-K4-M2GlyR diminished an established cAMP-ac-
tivated Cl3 secretory current in both MDCK mono-
layers [8] and in T84 monolayers (unpublished re-
sults). The decrease in current was evidently caused
by the insertion of Cl3 channels in the basolateral
membrane and the short-circuiting of Cl3 transport.
Polycationic peptides, such as protamine, on the oth-
er hand activate endogenous conductances such as
CFTR, therefore are e¡ective only when applied to
the apical surface. In the aggregate, these data sup-
port the hypothesis that C-K4-M2GlyR is associated
with the insertion of a novel anion conductance.
4.5. The activity of basolateral K+ channels modulates
Cl3 secretion induced by C-K4-M2GlyR
The results of several studies indicate that baso-
lateral K channels play a role in Cl3 secretion
[3,10,12,14,21]. Evidently, the hyperpolarization of
the cell membrane increases the electrochemical driv-
ing force for Cl3 secretion across the apical mem-
brane through constitutively active Cl3 channels [3].
In intestinal cells, Cl3 secretion is normally regulated
by both cAMP and Ca2 receptor-mediated agonists.
Elevation of intracellular cAMP activates the apical
membrane Cl3 conductance by stimulating protein
kinase A phosphorylation of the CFTR Cl3 channel.
Several studies have demonstrated that cAMP
may also activate a cAMP-dependent K channel;
although this channel has not been characterized by
patch clamp techniques [12,14,21]. The mechanism
for Ca2-mediated Cl3 secretion in T84 cells and
other intestinal cells is less well de¢ned. In polarized
T84 monolayers, factors that elevate intracellular
Ca2 levels have been shown to transiently increase
the rate of Cl3 secretion by activating basolateral K
conductance without increasing an apical Cl3 con-
ductance [3,19].
The antimycotic agent, clotrimazole, was shown to
inhibit both the cAMP- and the Ca2-dependent K
channels; however, there is a several-fold higher af-
¢nity for clotrimazole inhibition of the Ca2-depen-
dent K conductance (Ki = 0.3 WM) compared to the
cAMP-dependent K conductance (Ki = 5.2 WM)
[12]. In the current study, clotrimazole inhibited ISC
induced by C-K4-M2GlyR with an IC50 of 0.4 WM
(Fig. 2), consistent with clotrimazole’s a⁄nity for the
Ca2-dependent K channel reported by Devor and
associates [12]. Furthermore, prior treatment of the
T84 monolayers with CTX signi¢cantly reduced the
e¡ect of C-K4-M2GlyR (Fig. 3). These data suggest
that the Ca2-dependent K conductance is a major
K e¥ux pathway during Cl3 secretion caused by
membrane insertion of exogenous Cl3 channels into
the apical membrane of T84 cells.
Recently, 1-EBIO was shown to directly activate
the Ca2-dependent K channels in T84 cells and
potentiated the ISC response induced by the activa-
tion of the CFTR Cl3 channels [16]. Cuthbert et al.
showed that 1-EBIO has an EC50 close to 600 WM
[34], the dose also used by Devor and associates [16].
In the present study, the application of 600 WM
1-EBIO to the T84 cells stimulated a small but sus-
tained increase in ISC and hyperpolarized Vte,
changes that are consistent with Cl3 secretion (Table
2). The e¡ect was greatest when 1-EBIO was applied
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to both sides of the cell monolayer; however, the
addition of 1-EBIO to either the basolateral or the
apical medium was su⁄cient for a signi¢cant and
sustained increase in ISC (data on the apical applica-
tion are not shown).
Chloride and £uid secretion induced by exposing
the apical surface of the T84 monolayers to C-K4-
M2GlyR was greatly increased by 1-EBIO addition
to the basolateral media (Table 2, Fig. 7). The ISC
response to the combination of peptide and 1-EBIO
was reduced by clotrimazole (Fig. 5) and by CTX.
These data demonstrate that direct activation of the
Ca2-dependent K channels potentiates Cl3 secre-
tion induced by C-K4-M2GlyR.
Increasing intracellular Ca2 with A23187 failed to
potentiate the secretory response of C-K4-M2GlyR.
It has been shown that elevating intracellular Ca2
produces only a transient increase in Cl3 secretion
by T84 cells. It has been suggested that the transient
response of Ca2-mediated Cl3 secretion is due to
the activation of Ca2-dependent K channels fol-
lowed by a delayed inactivation of these channels
through a protein kinase C (PKC)-dependent process
[13]. In the current study, we speculate that PKC
activation, following a rise in cell Ca2 with
A23187, may limit the activity of the Ca2-dependent
K channel, preventing a potentiating e¡ect on Cl3
secretion induced by the peptide. A23187 did aug-
ment the response to direct activation of the K
channels with 1-EBIO in the presence of C-K4-
M2GlyR, an e¡ect that is consistent with the known
pharmacology of 1-EBIO. This compound does not
directly activate the Ca2-dependent K channel, but
rather increases the sensitivity of the K channel to
Ca2 [16]. Therefore, the combination of 1-EBIO
and increased cellular Ca2 act synergistically to in-
crease basolateral K conductance through Ca2-ac-
tivated K channels.
We found that 1-EBIO alone did not signi¢cantly
increase cAMP in T84 cells, data consistent with the
lack of an e¡ect of 1-EBIO on the cAMP-dependent
K channels in this cell line [16]. The increase in Cl3
and £uid secretion induced by combination of C-K4-
M2GlyR and 1-EBIO was independent of intracellu-
lar cAMP levels since the addition of the two com-
pounds did not signi¢cantly a¡ect cAMP content
(vcAMP was 6 10% of the forskolin response).
This implies that C-K4-M2GlyR and 1-EBIO had
minimal e¡ect on CFTR Cl3 conductance or other
cAMP-dependent processes. Therefore, we propose
that the major action of 1-EBIO is to activate the
Ca2-dependent K channels and that the increase in
the Cl3 secretory current is due to increasing the
driving force for Cl3 e¥ux through synthetic Cl3
channels generated by the membrane insertion of
C-K4-M2GlyR.
In summary, we have demonstrated that the syn-
thetic Cl3 channel-forming peptide, C-K4-M2GlyR,
induces Cl3 and £uid secretion by the human intes-
tinal cell line, T84. The magnitude of this response
can be modulated by activators and inhibitors of the
basolateral Ca2-dependent K conductance. We
propose that the combination of the novel synthetic
Cl3 channel-forming peptide, C-K4-M2GlyR, and
agents like 1-EBIO may have pharmacological bene-
¢ts for inducing and modulating transepithelial Cl3
and £uid secretion independent of the cAMP-depen-
dent Cl3 secretion that is impaired in cystic ¢brosis.
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